DK2087890T3 - Præparat med vedvarende frigørelse til vævsregenereringsterapi - Google Patents
Præparat med vedvarende frigørelse til vævsregenereringsterapiInfo
- Publication number
- DK2087890T3 DK2087890T3 DK07830074.6T DK07830074T DK2087890T3 DK 2087890 T3 DK2087890 T3 DK 2087890T3 DK 07830074 T DK07830074 T DK 07830074T DK 2087890 T3 DK2087890 T3 DK 2087890T3
- Authority
- DK
- Denmark
- Prior art keywords
- sustained release
- tissue regeneration
- release preparation
- regeneration therapy
- therapy
- Prior art date
Links
- 239000003405 delayed action preparation Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 230000017423 tissue regeneration Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006285357 | 2006-10-19 | ||
| PCT/JP2007/070340 WO2008047863A1 (en) | 2006-10-19 | 2007-10-18 | Sustained release preparation for tissue regeneration therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2087890T3 true DK2087890T3 (da) | 2014-05-19 |
Family
ID=39314081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07830074.6T DK2087890T3 (da) | 2006-10-19 | 2007-10-18 | Præparat med vedvarende frigørelse til vævsregenereringsterapi |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8617614B2 (da) |
| EP (1) | EP2087890B1 (da) |
| JP (1) | JP5423003B2 (da) |
| DK (1) | DK2087890T3 (da) |
| ES (1) | ES2459743T3 (da) |
| PL (1) | PL2087890T3 (da) |
| PT (1) | PT2087890E (da) |
| WO (1) | WO2008047863A1 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2393321T3 (es) | 2002-10-10 | 2012-12-20 | Ono Pharmaceutical Co., Ltd. | Promotores de la producción de factores de reparación endógenos |
| GB0814302D0 (en) | 2008-08-05 | 2008-10-01 | Coretherapix Slu | Compounds and methods |
| WO2014046065A1 (ja) | 2012-09-21 | 2014-03-27 | 国立大学法人大阪大学 | 心筋・血管再生デバイスとしての重症心不全治療材 |
| US20150272874A1 (en) | 2012-10-29 | 2015-10-01 | Cardio Incorporated | Pulmonary disease-specific therapeutic agent |
| JP6449166B2 (ja) * | 2013-10-15 | 2019-01-09 | 小野薬品工業株式会社 | 薬剤溶出性ステントグラフト |
| EP3569249A4 (en) * | 2016-12-27 | 2020-11-11 | Osaka University | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF REFRACTORY HEART DISEASE |
| WO2019102606A1 (ja) | 2017-11-27 | 2019-05-31 | 国立大学法人大阪大学 | 疾患部位特異的リポソーム製剤 |
| WO2020082083A1 (en) * | 2018-10-19 | 2020-04-23 | South Dakota Board Of Regents | Methods and compositions for localized intraductal drug delivery to the breast and regional lymph nodes |
| US11717656B2 (en) * | 2019-03-20 | 2023-08-08 | Gyros ACMI Inc. | Delivery of mixed phase media for the treatment of the anatomy |
| CN111035626B (zh) * | 2019-12-24 | 2021-08-06 | 山东大学第二医院 | 一种载罗氟司特药物的plga生物降解缓释制剂的制备方法 |
| CN114699535B (zh) * | 2022-01-29 | 2024-05-03 | 西北工业大学 | 一种微凝胶包覆金属有机框架的多效协同关节润滑剂及其制备方法 |
| US20240091163A1 (en) | 2022-09-09 | 2024-03-21 | Ricoh Company, Ltd. | Sustained releasing particle and method of producing sustained releasing particle |
| JP2025164729A (ja) | 2024-04-18 | 2025-10-30 | 株式会社リコー | 樹脂粒子、及び樹脂粒子の製造方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100191137B1 (ko) | 1992-07-21 | 1999-06-15 | 사노 가즈오 | 옥심 유도체 |
| JP2992677B2 (ja) | 1995-06-05 | 1999-12-20 | 武田薬品工業株式会社 | 骨形成促進医薬組成物 |
| MX9700850A (es) | 1995-06-09 | 1997-09-30 | Euro Celtique Sa | Formulaciones y metodos para proporcionar anestesia local prolongada. |
| JP2909418B2 (ja) | 1995-09-18 | 1999-06-23 | 株式会社資生堂 | 薬物の遅延放出型マイクロスフイア |
| ES2393321T3 (es) * | 2002-10-10 | 2012-12-20 | Ono Pharmaceutical Co., Ltd. | Promotores de la producción de factores de reparación endógenos |
| CA2518223A1 (en) * | 2003-03-26 | 2004-10-07 | Ltt Bio-Pharma Co., Ltd. | Intravenous nanoparticles for targeting drug delivery and sustained drug release |
-
2007
- 2007-10-18 PT PT78300746T patent/PT2087890E/pt unknown
- 2007-10-18 WO PCT/JP2007/070340 patent/WO2008047863A1/ja not_active Ceased
- 2007-10-18 PL PL07830074T patent/PL2087890T3/pl unknown
- 2007-10-18 ES ES07830074.6T patent/ES2459743T3/es active Active
- 2007-10-18 EP EP07830074.6A patent/EP2087890B1/en active Active
- 2007-10-18 JP JP2008539863A patent/JP5423003B2/ja active Active
- 2007-10-18 DK DK07830074.6T patent/DK2087890T3/da active
- 2007-10-18 US US12/446,157 patent/US8617614B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL2087890T3 (pl) | 2014-08-29 |
| EP2087890A1 (en) | 2009-08-12 |
| PT2087890E (pt) | 2014-05-12 |
| EP2087890B1 (en) | 2014-03-05 |
| ES2459743T3 (es) | 2014-05-12 |
| US20100323026A1 (en) | 2010-12-23 |
| JPWO2008047863A1 (ja) | 2010-02-25 |
| JP5423003B2 (ja) | 2014-02-19 |
| US8617614B2 (en) | 2013-12-31 |
| EP2087890A4 (en) | 2010-10-20 |
| WO2008047863A1 (en) | 2008-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2087890T3 (da) | Præparat med vedvarende frigørelse til vævsregenereringsterapi | |
| IL250734A0 (en) | Transdermal therapeutic system | |
| DK3424932T3 (da) | Bronophthalider til terapeutisk anvendelse | |
| DK3457135T3 (da) | Behandlingsmuligheder til fabrys sygdom | |
| PT2055308T (pt) | Medicamento para promover a regeneração funcional de tecido danificado | |
| DK1924151T3 (da) | Oral frigivelsessystem med styret frigivelse | |
| EP2119444A4 (en) | THERAPEUTIC AGENT FOR PAIN | |
| BRPI0916931A2 (pt) | agentes terapêuticos | |
| GB0609492D0 (en) | Therapeutic agents | |
| DK1959991T3 (da) | Terapeutisk vaccine | |
| DK2144905T3 (da) | Terapeutiske midler | |
| DK2035369T3 (da) | Terapeutiske | |
| GB0608928D0 (en) | Therapeutic agents | |
| HUE062920T2 (hu) | Eljárások vakcina beadására | |
| GB0601962D0 (en) | Therapeutic agents | |
| GB0723747D0 (en) | Therapeutic agents | |
| GB0616214D0 (en) | Therapeutic Agents | |
| DK2041128T3 (da) | Substituerede gamma-lactamer som terapeutiske agenser | |
| BRPI0818598A2 (pt) | agentes terapêuticos - 802 | |
| BRPI0716742A2 (pt) | Lactamas terapêuticas | |
| EP2061502A4 (en) | CARBOHYDRATE-BASED VACCINES FOR HLV | |
| ZA200809004B (en) | Autodestructive transdermal therapeutic system | |
| EP1968603A4 (en) | THERAPEUTIC AMINARYLSULFONAMIDE CONJUGATE COMPOUNDS | |
| GB0611152D0 (en) | Therapeutic agents | |
| ZA200900035B (en) | Prophylactic or therapeutic agent for viral disease |